TheraPanacea

What is your main idea?

TheraPanacea is a medical software company who envisions to change the paradigm of cancer diagnosis, prognosis and treatment through the introduction of artificial intelligence. ART-Suite, our first product will leverage collective intelligence and superior algorithms to bring any cancer radiotherapy team to perform at the same level of performance and care as the top 1% cancer centers in the world.

What is/was your biggest challenge so far?

Coupling the extreme potential of modern artificial intelligence methods with clinical domain expertise towards improving explicability of outcomes and acceptability from physicians. We thus co-develop our solutions with cancer reference centers and a unique combination of decision and deep AI. Physicians we work with are passionate about their work and patients well-being and believe firmly in innovation without fear of change.

What does a (good) partner mean for you?

A good partner is complementary in skills and assets, loyal, open to innovation and to co-development, constructive but still critical thinking with good balance in terms of mid and long term vision.